Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets (Parenthetical)

v3.23.3
Consolidated Balance Sheets (Parenthetical) - USD ($)
Jun. 30, 2023
Jun. 30, 2022
Statement of Financial Position [Abstract]    
Accounts receivable, allowance $ 420,354 $ 166,231
Revenues in excess of billings, allowance $ 1,380,141 $ 136,976
Preferred stock, par value $ 0.01 $ 0.01
Preferred stock, shares authorized 500,000 500,000
Common stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 14,500,000 14,500,000
Common stock, shares issued 12,284,887 12,196,570
Common stock, shares outstanding 11,345,856 11,257,539
Treasury stock, shares 939,031 939,031